Lysergic acid diethylamide (LSD) is a partial agonist of D2 dopaminergic receptors and it potentiates dopamine-mediated prolactin secretion in lactotrophs in vitro
Life Sciences June 1, 1998 Sabrina Giacomelli, Maura Palmery, Luca Romanelli et al. 51 citations
The hallucinogenic effects of lysergic acid diethylamide (LSD) have mainly been attributed to the interaction of this drug with the serotoninergic system, but it seems more likely that they are the result of the complex interactions of the drug with both the serotoninergic and dopaminergic systems. The aim of the present study was to investigate the functional actions of LSD at dopaminergic...
DOI: 10.1016/s0024-3205(98)00262-8 (opens in new tab)
Lysergic acid diethylamide
Dopaminergic
Prolactin cell
Bromocriptine
+5